Skip to main content

Carmen Pilar Simeón i Aznar

Institutions of which they are part

Main researcher
Systemic Diseases
Vall Hebron Institut de Recerca

Carmen Pilar Simeón i Aznar

Institutions of which they are part

Main researcher
Systemic Diseases
Vall Hebron Institut de Recerca

Research lines

Spanish Registry of Scleroderma patients (Systemic Autoimmune Diseases Group, Spanish Internal Medicine Association).

This multicentric study includes 14 hospitals with a cohort of 916 scleroderma patients. Its main goal consists in determining both the prognosis factors and the survival of these patients.

IP: Carmen Pilar Simeón i Aznar, Vicenç Fonollosa Pla

Significance of Capillaroscopy in Raynaud's phenomenon and scleroderma.

We want to describe the capillaroscopy alterations observed in patients with Raynaud's phenomenon and scleroderma. Our main objective is to establish the different patterns that may be related to visceral involvement and to the prognosis in the early stages of the disease.

IP: Carmen Pilar Simeón i Aznar, Vicenç Fonollosa Pla

Projects

ESTUDIO DE NUEVOS ANTIGENOS EN ESCLERODERMIA

IP: Carmen Pilar Simeón i Aznar
Collaborators: Vicenç Fonollosa Pla, Alfredo Guillen Del Castillo
Funding agency: Instituto de Salud Carlos III
Funding: 78650
Reference: PI16/02088
Duration: 01/01/2017 - 30/06/2021

Autoimmunitat i Malaltia Trombòtica (GRC)

IP: Miguel Vilardell Tarres
Collaborators: Carmen Pilar Simeón i Aznar, Roser Solans Laque, Segundo Bujan Rivas, Vicenç Fonollosa Pla, José Ordi Ros, Josefina Cortes Hernandez, Fernando Martínez Valle, Albert Selva O'Callaghan, Cristina Solé Marce
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding:
Reference: 2014 SGR 329
Duration: 01/01/2014 - 31/12/2016

Registry of the Spanish Network for Systemic Sclerosis: Clinical Pattern According to Cutaneous Subsets and Immunological Status

IP: Carmen Pilar Simeón i Aznar
Collaborators: -
Funding agency: Mutual Mèdica de Catalunya i Balears
Funding: 3000
Reference: PDJF-2012-01
Duration: 01/01/2013 - 31/12/2013

Autoimmunitat i malaltia trombòtica

IP: Miguel Vilardell Tarres
Collaborators: Carmen Pilar Simeón i Aznar, Ernesto Trallero Araguas, Roser Solans Laque, Segundo Bujan Rivas, Vicenç Fonollosa Pla, José Ordi Ros, Josefina Cortes Hernandez, Fernando Martínez Valle, Jesus Castro Marrero, Albert Selva O'Callaghan
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 49920
Reference: 2009 SGR 661
Duration: 01/01/2010 - 30/04/2014

Related news

The new technology allows more sensitive detection of scleroderma patients' autoantibodies, which are related to the severity and progression of the disease.

Researchers have used an innovative protocol to identify people with this autoimmune disease who have a higher risk of cancer.

It will allow the promotion of research on systemic autoimmune-based diseases that especially affect women of childbearing age and, therefore, can also appear during pregnancy.

Related professionals

Marc Cabrera Hurtado

Marc Cabrera Hurtado

Research technician
Gene Therapy at Nervous System
Read more
Sheila Garcia  Prado

Sheila Garcia Prado

Psychiatry, Mental Health and Addictions
Read more
Pedro Serrano Pérez

Pedro Serrano Pérez

Research technician
Psychiatry, Mental Health and Addictions
Read more
Sara García González

Sara García González

Research technician
Psychiatry, Mental Health and Addictions
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.